Nona Biosciences and Lonza Enter Strategic Collaboration to Develop Best-in-Class Single-Domain Antibody-Based BBB-Crossing Technology for CNS Diseases - Thailand PR News - [Banking](https://thailandbusinessnews.net/category/banking/) - [Companies](https://thailandbusinessnews.net/category/companies/) - [Economy](https://thailandbusinessnews.net/category/economy/) - [Press Releases](https://thailandbusinessnews.net/category/press-release/) - [PR Newswire](https://thailandbusinessnews.net/pr-newswire-updates/) - [Tech](https://thailandbusinessnews.net/category/tech/) - [Tourism](https://thailandbusinessnews.net/category/tourism/) - [Press Release](https://thailandbusinessnews.net/category/press-release/) - [Tech](https://thailandbusinessnews.net/category/tech/) # Nona Biosciences and Lonza Enter Strategic Collaboration to Develop Best-in-Class Single-Domain Antibody-Based BBB-Crossing Technology for CNS Diseases ##### Up next ![Trinasolar Showcases Vertex N G3 at ASEW to Support Thailand's Solar Market Amid Rising AI and Data Centre Demand](https://i0.wp.com/mma.prnasia.com/media2/3002984/Image_20260701101426_106_59.jpg?resize=200%2C110&ssl=1 "Trinasolar Showcases Vertex N G3 at ASEW to Support Thailand's Solar Market Amid Rising AI and Data Centre Demand") [](https://thailandbusinessnews.net/press-release/trinasolar-showcases-vertex-n-g3-at-asew-to-support-thailands-solar-market-amid-rising-ai-and-data-centre-demand/) ###### [Trinasolar Showcases Vertex N G3 at ASEW to Support Thailand's Solar Market Amid Rising AI and Data Centre Demand](https://thailandbusinessnews.net/press-release/trinasolar-showcases-vertex-n-g3-at-asew-to-support-thailands-solar-market-amid-rising-ai-and-data-centre-demand/) Published on 02 July 2026 ##### Author ##### [ CISION PRNewswire ](https://thailandbusinessnews.net/author/cision/) ##### Tags - [PRNewswire](https://thailandbusinessnews.net/tag/prnewswire/) ![](https://mma.prnasia.com/media2/2971749/image1_Logo.jpg?p=medium600 "logo")CAMBRIDGE, Mass., July 2, 2026 /PRNewswire/ — Nona Biosciences ("Nona"), a global biotechnology company advancing biologics discovery and development through innovative technology platforms, today announced a strategic collaboration with Lonza to develop best-in-class single-domain antibody–based blood-brain barrier (BBB)-crossing technology for central nervous system (CNS) diseases. This collaboration will leverage Nona Biosciences’ proprietary Harbour Mice® fully human HCAb platform to discover and develop next-generation single-domain antibody-based blood-brain barrier (BBB)-crossing technologies. Leveraging the platform’s proven ability to generate fully human HCAbs and VHH binders with exceptional affinity and developability, the partnership aims to establish a best-in-class BBB-crossing technology capable of enabling the delivery of a diverse range of therapeutic modalities into the central nervous system (CNS) and unlocking new opportunities in CNS drug development and technology licensing. As part of the collaboration, Lonza’s protein development expertise, world-leading GS Gene Expression System® and GlycoConnect® bioconjugation technology will complement Nona’s platform by supporting the optimization and broader application of selected BBB-crossing candidates. Under the terms of the agreement, Nona is entitled to receive upfront and option payments from Lonza. The parties will also share revenues generated from future licensing agreements pursuant to the collaboration. Dr. Jingsong Wang, Chairman of Nona Biosciences, commented: "This partnership reflects validates Nona’s platform and strategic focus in next-generation delivery technologies. Lonza’s global reach, regulatory expertise, and commercial manufacturing capabilities will help accelerate the advancement of our BBB-crossing-technology. Beyond technology development, the collaboration creates opportunities for licensing, commercialization and long-term value creation, while strengthening our position in the CNS delivery space and supporting better outcomes for patients." Dr. Di Hong, Chief Executive Officer of Nona Biosciences, added: "We are excited to partner with Lonza to develop and commercialize best-in-class BBB-crossing technologies for CNS diseases. This collaboration underscores the power and versatility of our HCAb Harbour Mice® platform and its ability to generate differentiated, fully human single-domain binders that can tackle the most challenging delivery barriers in drug development. By combining our platform with Lonza’s services and development and manufacturing expertise, we are confident to offer next-generation BBB-crossing solutions that can unlock new treatment paradigms for patients suffering from devastating CNS disorders." Peter Droc, Head of Licensing, Lonza, commented: "With the acquisition of IP rights to Nona’s BBB-crossing technology and through our continued collaboration, we are immediately enabling our customers to translate promising CNS assets into viable therapeutics. By combining this with flexible CDMO services, we allow partners to engage with us at any stage of their journey – from technology licensing to fully integrated development and commercial manufacturing – reducing complexity and helping accelerate the path to patients." **About Nona Biosciences** Nona Biosciences, a wholly owned subsidiary of HBM Holding Limited (HKEX:02142), is a global biotechnology company committed to advancing biotherapeutic innovation through cutting-edge technology platforms and integrated solutions. Nona supports programs with its I to I® framework, from early-stage ideas through preclinical research and advancement toward IND and early clinic, spanning target validation and antibody discovery to early development. Nona’s proprietary Harbour Mice® technology platform generates fully human monoclonal antibodies in classical two light and two heavy chain (H2L2) format, and heavy chain-only (HCAb) format. The HCAb Harbour Mice® is the world’s first fully human HCAb transgenic mouse with clinical validation. This unique platform offers exceptional versatility for diverse applications using fully human VH single-domain antibodies as a plug-and-play system, including bispecific antibodies, multi-specific antibodies, CAR-T therapies, antibody-drug conjugates (ADCs), mRNA-based therapeutics, and more. By integrating Harbour Mice®, single-B cell screening technology, NonaCarFx™ (a direct CAR-function-based screening platform), Hu-mAtrIx™ (an AI-driven drug discovery platform), Modalities-on-Demand® (a next-generation modalities solution), and end-to-end preclinical drug development services, Nona Biosciences is dedicated to driving the global invention of transformative next-generation drugs. For more information, please visit: **[www.nonabio.com](https://www.nonabio.com/)**. [Source link ](http://www.prnasia.com/story/archive/4996512_CN96512_0?rand=89749) ``` This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network ``` ##### You May Also Like [](https://thailandbusinessnews.net/press-release/ecozy-launches-black-friday-ice-maker-series-deals-holiday-gift-picks-at-the-years-lowest-prices/) ![ecozy Launches Black Friday Ice Maker Series Deals–Holiday Gift Picks at the Year's Lowest Prices](https://i0.wp.com/r2.thailandbusinessnews.net/2025/11/image_5032868_35617289.jpg?resize=260%2C140&ssl=1 "ecozy Launches Black Friday Ice Maker Series Deals–Holiday Gift Picks at the Year's Lowest Prices") - [Press Release](https://thailandbusinessnews.net/category/press-release/) ## ecozy Launches Black Friday Ice Maker Series Deals–Holiday Gift Picks at the Year's Lowest Prices FULLERTON, Calif., Nov. 20, 2025 /PRNewswire/ — ecozy, a leader in innovative… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - November 20, 2025 [](https://thailandbusinessnews.net/press-release/agoda-reveals-growing-travel-interest-for-2026-silver-week-in-japan-driven-by-first-five-day-holiday-in-11-years/) ## Agoda Reveals Growing Travel Interest for 2026 Silver Week in Japan, Driven by First Five-Day Holiday in 11 Years ―Overseas accommodation searches rise 131%, while domestic searches increase 120%, as Respect… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - September 4, 2026 [](https://thailandbusinessnews.net/press-release/meraki-global-advisors-appoints-joe-hodgkins-as-head-of-asia-pacific-trading/) ## Meraki Global Advisors Appoints Joe Hodgkins as Head of Asia Pacific Trading Strategic hire from Tourmaline Partners deepens Meraki’s buy-side trading expertise and reinforces… - [CISION PRNewswire](https://thailandbusinessnews.net/author/cision/ "View all posts by CISION PRNewswire") - May 19, 2025 ##### Most Read - [![Finloop Raises Over US$10 Million in Series A+ Financing, Welcomes HSBC as One of its Strategic Investors, and Launches Its Corporate Service "Finterprise"](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/finloop-raises-over-us10-million-in-series-a-financing-welcomes-hsbc-as-one-of-its-strategic-investors-and-launches-its-corporate-service-finterprise/ "Finloop Raises Over US$10 Million in Series A+ Financing, Welcomes HSBC as One of its Strategic Investors, and Launches Its Corporate Service "Finterprise"") [Finloop Raises Over US$10 Million in Series A+ Financing, Welcomes HSBC as One of its Strategic Investors, and Launches Its Corporate Service "Finterprise"](https://thailandbusinessnews.net/press-release/finloop-raises-over-us10-million-in-series-a-financing-welcomes-hsbc-as-one-of-its-strategic-investors-and-launches-its-corporate-service-finterprise/ "Finloop Raises Over US$10 Million in Series A+ Financing, Welcomes HSBC as One of its Strategic Investors, and Launches Its Corporate Service "Finterprise"") - [![Chubb Wealth Debuts Evergreen Private Markets Fund Series with S64](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/chubb-wealth-debuts-evergreen-private-markets-fund-series-with-s64/ "Chubb Wealth Debuts Evergreen Private Markets Fund Series with S64") [Chubb Wealth Debuts Evergreen Private Markets Fund Series with S64](https://thailandbusinessnews.net/press-release/chubb-wealth-debuts-evergreen-private-markets-fund-series-with-s64/ "Chubb Wealth Debuts Evergreen Private Markets Fund Series with S64") - [![Triton Uranium Advances Atlas Project, Reports Exploration Target of 46.56 Million Pounds of Uranium](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/triton-uranium-advances-atlas-project-reports-exploration-target-of-46-56-million-pounds-of-uranium/ "Triton Uranium Advances Atlas Project, Reports Exploration Target of 46.56 Million Pounds of Uranium") [Triton Uranium Advances Atlas Project, Reports Exploration Target of 46.56 Million Pounds of Uranium](https://thailandbusinessnews.net/press-release/triton-uranium-advances-atlas-project-reports-exploration-target-of-46-56-million-pounds-of-uranium/ "Triton Uranium Advances Atlas Project, Reports Exploration Target of 46.56 Million Pounds of Uranium") - [![Adecco Group announces Salesforce's Agentforce Coworker rollout across 40 countries](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/adecco-group-announces-salesforces-agentforce-coworker-rollout-across-40-countries/ "Adecco Group announces Salesforce's Agentforce Coworker rollout across 40 countries") [Adecco Group announces Salesforce's Agentforce Coworker rollout across 40 countries](https://thailandbusinessnews.net/press-release/adecco-group-announces-salesforces-agentforce-coworker-rollout-across-40-countries/ "Adecco Group announces Salesforce's Agentforce Coworker rollout across 40 countries") - [![GCCL and Medicover Integrated Clinical Services Announce Strategic Collaboration to Strengthen Multinational Clinical Trial Services](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/gccl-and-medicover-integrated-clinical-services-announce-strategic-collaboration-to-strengthen-multinational-clinical-trial-services/ "GCCL and Medicover Integrated Clinical Services Announce Strategic Collaboration to Strengthen Multinational Clinical Trial Services") [GCCL and Medicover Integrated Clinical Services Announce Strategic Collaboration to Strengthen Multinational Clinical Trial Services](https://thailandbusinessnews.net/press-release/gccl-and-medicover-integrated-clinical-services-announce-strategic-collaboration-to-strengthen-multinational-clinical-trial-services/ "GCCL and Medicover Integrated Clinical Services Announce Strategic Collaboration to Strengthen Multinational Clinical Trial Services") - [![600 Clubs Strong: Inspire Brands Asia Continues Regional Expansion, Affirms Vision for 1,000 by 2028](https://secure.gravatar.com/avatar/96e712b5408b51145de772098c3ff3417ce8a11555b7c388d84204c5769f5631?s=40&d=blank&r=g)](https://thailandbusinessnews.net/press-release/600-clubs-strong-inspire-brands-asia-continues-regional-expansion-affirms-vision-for-1000-by-2028/ "600 Clubs Strong: Inspire Brands Asia Continues Regional Expansion, Affirms Vision for 1,000 by 2028") [600 Clubs Strong: Inspire Brands Asia Continues Regional Expansion, Affirms Vision for 1,000 by 2028](https://thailandbusinessnews.net/press-release/600-clubs-strong-inspire-brands-asia-continues-regional-expansion-affirms-vision-for-1000-by-2028/ "600 Clubs Strong: Inspire Brands Asia Continues Regional Expansion, Affirms Vision for 1,000 by 2028") ##### Subscribe via Email Enter your email address to subscribe and receive notifications of new posts by email. Email Address Subscribe [](https://thailandbusinessnews.net/press-release/cellebrite-expands-global-digital-community-the-101-for-digital-forensics-and-investigative-professionals/) ![Cellebrite Expands Global Digital Community, 'The 101', for Digital Forensics and Investigative Professionals](https://i0.wp.com/mmx.prnasia.com/media/MS1775952/Cellebrite-Logo.jpg?resize=260%2C140&ssl=1 "Cellebrite Expands Global Digital Community, 'The 101', for Digital Forensics and Investigative Professionals") ## Cellebrite Expands Global Digital Community, 'The 101', for Digital Forensics and Investigative Professionals Purpose-built platform connects customers worldwide with peers and Cellebrite experts… [](https://thailandbusinessnews.net/press-release/eightco-holdings-nasdaq-orbs-reports-total-holdings-of-approximately-380-million-includes-openai-beast-industries-more-than-16000-eth-and-nearly-302-million-wld-tokens-2/) ![Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings of Approximately 0 Million, Includes OpenAI, Beast Industries, More Than 16,000 ETH and Nearly 302 Million WLD Tokens](https://i0.wp.com/mmx.prnasia.com/media/MS695659/Eightco-Logo.jpg?resize=260%2C140&ssl=1 "Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings of Approximately 0 Million, Includes OpenAI, Beast Industries, More Than 16,000 ETH and Nearly 302 Million WLD Tokens") ## Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings of Approximately $380 Million, Includes OpenAI, Beast Industries, More Than 16,000 ETH and Nearly 302 Million WLD Tokens Eightco treasury composition as of September 16, 2026: $90M OpenAI equity (indirect),… [](https://thailandbusinessnews.net/press-release/theres-no-one-size-fits-all-for-treating-older-adults-with-cancer-according-to-new-nccn-patient-resource/) ## There's No One-Size-Fits-All for Treating Older Adults with Cancer, According to New NCCN Patient Resource New guideline for patients and caregivers explains the importance of assessments to… [](https://thailandbusinessnews.net/press-release/loccitane-group-achieves-a-new-milestone-in-its-b-corp-certification-journey/) ![L'OCCITANE Group achieves a new milestone in its B Corp™ certification journey](https://i0.wp.com/mmx.prnasia.com/media/MS1989037/Key_Visual_Vertical_2_No_Border-T.jpg?resize=260%2C140&ssl=1 "L'OCCITANE Group achieves a new milestone in its B Corp™ certification journey") ## L'OCCITANE Group achieves a new milestone in its B Corp™ certification journey Progress is measured not only by what is achieved, but by the…